Human height is one of the most well-known examples of polygenic inheritance, a pattern where many genes each contribute a small effect to produce a single trait. Unlike simple inheritance, where one gene controls one outcome (like the gene variant that causes sickle cell disease), polygenic traits are shaped by hundreds or even thousands of genetic variants working together. Height, skin color, eye color, and the risk for diseases like type 2 diabetes all follow this pattern.
How Polygenic Inheritance Works
In simple (monogenic) inheritance, a mutation in a single gene can cause a clear-cut outcome. A cleft chin or face freckles, for instance, trace back to one gene. Monogenic conditions tend to be rare and follow predictable dominant or recessive patterns. Polygenic inheritance is fundamentally different. Instead of one gene calling the shots, dozens, hundreds, or thousands of genes each nudge the trait in one direction. Geneticists call these “additive effects” because the independent contributions of many alleles stack on top of each other.
This is why polygenic traits don’t sort neatly into two or three categories. They produce a continuous spectrum of outcomes across a population, typically forming the familiar bell curve. Most people cluster around an average value, with fewer people at the extremes. You don’t see people who are either “tall” or “short” with nothing in between. You see every possible height in small increments, precisely because so many genes are involved.
Human Height: The Classic Example
Height is the textbook case of polygenic inheritance, and recent genetics research reveals just how many genes are at play. A 2022 genome-wide association study of 5.4 million people identified 12,111 independent DNA variants significantly associated with height. These variants cluster within roughly 7,209 segments of the genome, covering about 21% of it. Together, they account for nearly all of the common genetic contribution to how tall someone grows.
Each of these variants has a tiny individual effect. No single “tall gene” exists. Instead, inheriting more height-increasing variants tends to make you taller, and inheriting fewer tends to make you shorter. The cumulative result is the smooth bell curve of heights you see in any large group of people. On rare occasions, a variant in a single gene can have a dramatic effect. Variants in one growth-related gene cause achondroplasia, a condition characterized by significantly short stature. But these cases are the exception, not the rule.
Height is also a clear example of how environment interacts with polygenic traits. Nutrition during childhood, overall health, and even sleep patterns influence how much of your genetic height potential you actually reach. Two people with identical DNA variants for height could end up at different heights if one experienced chronic malnutrition during development.
Skin Color
Skin pigmentation is another striking example. The range of human skin tones exists because multiple genes control how much melanin your skin cells produce, what type of melanin they make, and how it’s packaged and distributed. At least four major genes play central roles, along with a constellation of additional ones.
The MC1R gene determines the balance between two types of melanin: a brown-black form and a red-yellow form. Certain variants of this gene are common in European populations and shift production toward lighter pigmentation. The SLC24A5 gene affects the internal chemistry of the tiny compartments where melanin is manufactured inside skin cells. One specific variant of this gene is nearly universal in European populations and rare in African populations, and it significantly lightens skin tone. The TYR gene encodes the key enzyme that kicks off melanin production in the first place, acting as the rate-limiting step in the entire process.
These genes don’t operate in isolation. Their combined variation, along with contributions from many other pigmentation genes, creates the broad and continuous spectrum of skin tones seen across human populations. Sun exposure further modifies the outcome by stimulating melanin production, which is why the same person can have noticeably different skin tones depending on the season.
Eye Color
Eye color was once taught as a simple dominant-recessive trait: brown was dominant, blue was recessive, and two blue-eyed parents could never have a brown-eyed child. That model turned out to be wrong. Eye color is polygenic, and two blue-eyed parents can indeed have a brown-eyed child, though it’s uncommon.
The biggest influence comes from two genes sitting close together on chromosome 15. The OCA2 gene produces a protein involved in maturing the cellular structures that make and store melanin in the iris. Common variants in OCA2 reduce how much of this protein gets made, resulting in less melanin and lighter eye colors. Right next door, the HERC2 gene contains a regulatory segment that acts like a dimmer switch for OCA2, turning its activity up or down. A specific variant in HERC2 dials down OCA2 expression, which means less melanin and lighter eyes.
Beyond these two, at least eight other genes contribute smaller effects, including some of the same genes involved in skin and hair color (like SLC24A5 and TYR). The combined influence of all these genes produces the full continuum of eye colors, from very dark brown through hazel, green, and blue, with countless subtle shades in between.
Type 2 Diabetes and Complex Diseases
Polygenic inheritance isn’t limited to visible physical traits. Many common diseases, including type 2 diabetes, heart disease, and certain cancers, have a polygenic foundation. No single gene causes type 2 diabetes. Instead, many genetic variants across the genome each slightly increase or decrease your risk. Researchers now quantify this using polygenic risk scores, which add up the effects of all known risk variants in a person’s DNA to estimate their overall genetic susceptibility.
For type 2 diabetes, these scores can explain up to about 15% of the familial risk across populations. The scores also predict related health outcomes: people with higher genetic risk scores for type 2 diabetes tend to have higher blood pressure, higher triglycerides, and lower levels of protective HDL cholesterol, even before they develop diabetes. The genetic risk connects to complications like retinopathy, kidney disease, and cardiovascular problems.
Importantly, genetic risk scores for type 2 diabetes perform differently depending on context. They’re more predictive in younger people and in those who aren’t already obese. This highlights a key feature of polygenic diseases: environmental factors like diet, exercise, and body weight interact with genetic predisposition. Someone with a high genetic risk score who maintains a healthy weight may never develop the disease, while someone with moderate genetic risk and significant obesity might. Similar polygenic patterns have been documented for coronary artery disease, prostate cancer, colorectal cancer, and breast cancer.
Intelligence and Cognitive Traits
Intelligence is among the most highly polygenic traits studied. Genome-wide association studies have identified thousands of DNA variants that contribute, but even the most strongly associated single variant explains less than 1% of the variation in cognitive ability across a population. The rest of the genetic influence is spread across an enormous number of variants, each with a tiny effect, consistent with what geneticists call the “infinitesimal model” first proposed over a century ago.
Polygenic scores for cognitive ability do capture some aspects of intelligence better than others. They tend to predict verbal and numerical reasoning more accurately than memory, likely because the large studies used to discover relevant variants measured some cognitive skills more thoroughly than others. As with other polygenic traits, environment plays a major role. Nutrition, education, socioeconomic status, and early childhood experiences all interact with genetic predisposition. Children with higher genetic risk scores for attention difficulties, for example, show disproportionately more behavioral problems when raised in high-stress environments, a pattern researchers call gene-environment interaction.
Why Polygenic Traits Differ From Single-Gene Traits
The practical difference between polygenic and monogenic inheritance comes down to predictability and severity. Monogenic diseases like cystic fibrosis or sickle cell disease are caused by a mutation in one gene. They follow clear inheritance patterns, are relatively easy to test for through carrier screening, and tend to be rare but severe. If you carry the relevant mutation, the outcome is fairly predictable.
Polygenic traits and diseases are the opposite in almost every way. They’re common, harder to predict, and heavily shaped by lifestyle and environment. You can’t point to one gene and say “this is the cause.” Instead, it’s the cumulative weight of many small genetic nudges, combined with life circumstances, that determines the outcome. This is why conditions like heart disease and type 2 diabetes run in families without following a neat Mendelian pattern, and why identical twins can differ in height, weight, or disease risk despite sharing the same DNA.